Scientists led by a team from Duke-NUS Medical School in Singapore have identified three distinct serotypes of SARS-rela...
South Korea-based SK bioscience has entered into a collaboration agreement with Vaxxas, an Australian biotechnology comp...
Japan-based Nagasaki University and NEC OncoImmunity (NOI), a leading artificial intelligence (AI) company, will c...
US-based Arcturus Therapeutics Holdings Inc., has announced that ARCALIS Co., its manufacturing joint venture in Japan t...
Australia's University of Adelaide researchers have started work on developing a new vaccine that could help ward off pa...
South Korea-based SK bioscience, an innovative vaccine and biotech company, has decided to make an equity investment in ...
Bio Farma Induk Holding BUMN Pharmacy, with its subsidiaries Kimia Farma and Indofarma, in collaboration with Merck Shar...
Toyo Ink SC Holdings, the parent company of Japan-based specialty chemicals manufacturer Toyo Ink Group, has concluded...
Zuellig Pharma, one of the largest healthcare services groups in Asia, has entered into an agreement with global biophar...
What are the key opportunities and challenges for APAC vaccine manufacturers in adopting and utilising mRNA technology?&...
GC Biopharma, a South Korean biopharmaceutical company, has announced that its quadrivalent flu vaccine called GC F...
GSK Singapore commemorated the groundbreaking ceremony for its S$343 million state-of-the-art vaccines facility at Tuas ...
Lifera, a biopharmaceutical company in Saudi Arabia together with French multinational pharmaceutical and healthcar...
South Korea-based biotech firm SK bioscience has signed a Memorandum of Understanding (MoU) with the Government Pha...
British firm GlaxoSmithKline (GSK) has announced that the Japanese Ministry of Health, Labour and Welfare (MHL...
SK bioscience, a global innovative vaccine and biotech company based in South Korea, has signed a collaboratio...
The International Vaccine Institute (IVI) and Seoul National University signed an agreement to expand collaboration in r...
Vaxxas, a clinical-stage biotechnology company commercialising a novel vaccination platform technology, has announced th...
